Relationships of upper gastrointestinal motor and sensory function with glycemic control

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 371-381

  Rayner, Christopher K ^a   Samsom, Melvin ^b   Jones, Karen L ^a   Horowitz, Michael ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

DIABETES CONTROL; DIABETES MELLITUS; ESOPHAGUS MOTILITY; GALLBLADDER MOTILITY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT FUNCTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INTESTINE MOTILITY; LIVER METABOLISM; POSTPRANDIAL STATE; REVIEW; STOMACH EMPTYING; STOMACH MOTILITY;

EID: 0035141010     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.371     Document Type: Review

References (138)

1. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes
2. Diabetes mellitus is associated with an increased prevalence of gastrointestinal symptoms: Results from a population-based survey of 15,000 adults
3. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus
4. Gastrointestinal symptoms in diabetes are associated with diabetic complications but not with current glycemic control
5. Disordered gastric emptying: Mechanical basis, assessment and treatment
6. Effect of acute hyperglycemia on esophageal motility and lower esophageal sphincter pressure in humans
7. Physiological variations in blood glucose concentration affect oesophageal motility and sensation in normal subjects
8. Hyperglycemia stimulates transient lower esophageal sphincter relaxations in normal subjects
9. The effect of acute hyperglycemia on gastric emptying in man
10. The influence of induced hyperglycemia on gastric emptying in healthy humans
11. Hypoglycemia increases the gastric emptying rate in healthy subjects
12. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus
13. Hyperglycaemia slows gastric emptying in type 1 diabetes mellitus
14. Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus
15. Gastric and oesophageal emptying in patients with type 2 (noninsulin-dependent) diabetes mellitus
16. Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus
17. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects
18. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus
19. Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects
20. Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion
21. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: Effects of hyperglycemia
22. Serum glucose concentration as a modulator of interdigestive gastric motility
23. Effects of hyperglycemia On interdigestive gastrointestinal motility in humans
24. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins
25. Hyperglycaemia stimulates pyloric motility in normal subjects
26. Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia
27. The influence of induced hyperglycaemia on the characteristics of intestinal motility and bile kinetics in healthy men
28. Hyperglycemia modulates gallbladder motility and small intestinal transit time in man
29. The effect of acute hyperglycaemia on small intestinal motility in normal subjects
30. Hyperglycaemia affects gastric electrical rhythm and nausea during intraduodenal triglyceride infusion
31. Physiological changes in blood glucose affect appetite and pyloric motility during intraduodenal lipid infusion
32. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
34. The emerging role of postprandial hyperglycaemic spikes in the pathogenesis of diabetic complications
35. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC 137, a human amylin analogue
36. Relationship between esophageal motility and transit in patients with type I diabetes mellitus
37. Gastroesophageal reflux in diabetes mellitus
38. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
39. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux
40. The effect of the intravenous administration of various nutrients on the gastric hunger contractions of a man with severe brain damage
41. Gastric emptying and change of blood glucose level, as affected by glucagon and insulin
42. Diabetes and the stomach
43. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis
44. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration
45. Hyperglycaemia and absorption of sulphonylurea drugs
46. Relation of pyloric motility to pyloric opening and closure in healthy subjects
47. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion
48. Gastrointestinal electrical activity: Terminology
49. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis
50. Physiological changes in blood glucose do not affect gastric compliance and perception in normal subjects
51. The stimulation of antral motility by erythromycin is attenuated by hyperglycaemia
52. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type 1 diabetes mellitus
53. Effects of cholecystokinin on appetite and pyloric motility during physiological hyperglycemia
54. Effect of insulin-induced hypoglycaemia on antral, pyloric and duodenal motility in fasting subjects
55. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus
56. Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans
57. Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia
58. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans
59. Effect of acute hyperglycemia on colorectal motor and sensory function in humans
60. Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects
61. Hyperglycemia-induced attenuation of rectal perception depends upon pattern of rectal balloon inflation
62. Hyperglycemia alters perception of rectal distention and blunts the rectoanal inhibitory reflex in healthy volunteers
63. Hyperglycemia blunts rectal afferent transmission and increases rectal compliance in diabetic patients: A possible model of diabetic constipation
64. Effects of acute hyperglycemia on anorectal function in diabetes mellitus
65. Disorders of gastrointestinal motility associated with diabetes mellitus
66. The effect of acute hyperglycaemia on meal-stimulated gastric, biliary, and pancreatic secretion, and serum gastrin
67. Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans
68. Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans
69. Effects of hyperglycemia on cortical response to esophageal distension in normal subjects
70. Appetite regulation by carbohydrate: Role of blood glucose and gastrointestinal hormones
71. The blood glucose concentration influences postprandial fullness in IDDM
72. Glucose responding neurons in the nucleus tractus solitarius of the rat: In vitro study
73. Mechanism of pain in diabetic peripheral neuropathy: Effect of glucose on pain perception in humans
74. Blood glucose and human memory
75. Blood glucose influences memory and attention in young adults
76. Memory enhancement in elderly humans: Effects of glucose ingestion
77. The impact of raising blood glucose on reaction times
78. Symptoms and well-being in relation to glycemic control in type II diabetes
79. Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects
80. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of the fundus
81. Evidence that nitric oxide mechanisms regulate small intestinal motility in humans
82. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats
83. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy
84. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility
85. Identification and characterization of glucoresponsive neurons in the enteric nervous system
86. Hyperinsulinemia impairs gastrointestinal motility and slows carbohydrate absorption
87. Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus
88. Endogenous nitric oxide in the regulation of gastric secretory and motor activity in humans
89. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects
90. Gastric emptying in early noninsulin-dependent diabetes mellitus
91. Altered postprandial insulin requirement in IDDM patients with gastroparesis
92. Food properties affecting the digestion and absorption of carbohydrates
93. Relationship between the rate of gastric emptying and glucose and insulin responses to starchy foods in young healthy adults
94. Physiological regulation of gastric emptying and glucose absorption
95. Effect of different starchy foods in composite meals on gastric emptying rate and glucose metabolism. I. Comparisons between potatoes, rice and white beans
96. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus
97. Gastric emptying of a solid meal is accelerated by the removal of dietary fibre naturally present in food
98. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: Possible implications for the dietary management of diabetes mellitus
99. Effect of short-term starvation on gastric emptying in humans: Relationship to oral glucose tolerance
100. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans
101. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man
102. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1
103. Pharmacology of α-glucosidase inhibition
104. Inhibition of glucose absorption in the rat jejunum: A novel action of alpha-D-glucosidase inhibitors
105. Effects of diabetes and hyperglycemia on disaccharidase activities in the rat
106. Digestion and absorption of carbohydrates: From molecules and membranes to humans
107. Regulation of intestinal glucose transport
108. Induction of intestinal glucose carriers in streptozocin-treated chronically diabetic rats
109. Effect of insulin, glucose, and controlled diabetes mellitus on human jejunal function
110. Intestinal glucose and amino acid absorption in healthy volunteers and noninsulin-dependent diabetic subjects
111. Small intestinal glucose absorption is increased in type 1 diabetes mellitus
112. Involvement of small intestinal motility in blood glucose response to dietary fibre in man
113. Inhibition of small intestinal motility decreases glucose absorption in humans
114. Abnormal intestinal motility in diabetics with the gastroparesis syndrome
115. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea
116. Relationships between dyspeptic symptoms and gastrointestinal motility in patients with type 1 diabetes mellitus
117. Gastrointestinal motility disorders in patients with diabetes mellitus
118. Superior mesenteric artery blood flow and gastric emptying in humans and the differential effects of high fat and high carbohydrate meals
119. Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs
120. Impaired glucose sensing by intrahepatic, muscarinic nerves for an insulin-stimulated hepatic glucose uptake in streptozotocin-diabetic rats
121. Initial splanchnic extraction of ingested glucose in normal man
122. The disposal of an oral glucose load in healthy subjects: A quantitative study
123. Abnormal meal carbohydrate disposition in insulin-dependent diabetes: Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy
124. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus
125. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis
126. Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: A dodble blind cross-over trial
127. Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients
128. Dietary guar gum effects on postprandial blood glucose, insulin and hydroxyproline in humans
129. Pramlintide: A human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes
130. Pramlintide, an amylin analog, selectively delays gastric emptying: Potential role of vagal inhibition
131. The role of amylin in the physiology of glycemic control
132. Clinical implications of amylin and amylin deficiency
133. Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: Effects on plasma glucose profiles and serum fructosamine concentrations
134. Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin: The Pramlintide in Type 2 Diabetes Group
135. Modulation of gastric emptying as a therapeutic approach to glycaemic control
136. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes
137. Glucagon-like peptide-1: A potent regulator of food intake in humans
138. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men